Corticothalamic network dysfunction and behavioral deficits in a mouse model of Alzheimer's disease

被引:23
|
作者
Hazra, Anupam [1 ,2 ]
Corbett, Brian F. [1 ,2 ]
You, Jason C. [1 ,2 ]
Aschmies, Suzan [1 ,2 ]
Zhao, Lijuan [1 ,2 ]
Li, Ke [1 ,2 ]
Lepore, Angelo C. [1 ,2 ]
Marsh, Eric D. [3 ,4 ]
Chin, Jeannie [1 ,2 ,5 ]
机构
[1] Thomas Jefferson Univ, Dept Neurosci, Philadelphia, PA 19107 USA
[2] Thomas Jefferson Univ, Farber Inst Neurosci, Philadelphia, PA 19107 USA
[3] Univ Penn, Childrens Hosp Philadelphia, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA
[4] Univ Penn, Childrens Hosp Philadelphia, Dept Neurol, Perelman Sch Med, Philadelphia, PA 19104 USA
[5] Baylor Coll Med, Dept Neurosci, Memory & Brain Res Ctr, 1 Baylor Plaza,S707, Houston, TX 77030 USA
基金
美国国家卫生研究院;
关键词
Alzheimer's disease; Seizure; Epilepsy; Corticothalamic; Amyloid precursor protein; Sleep fragmentation; Reticular thalamic nucleus (nRT); ATYPICAL ABSENCE SEIZURES; MILD COGNITIVE IMPAIRMENT; AMYLOID-PRECURSOR-PROTEIN; SPIKE-WAVE DISCHARGES; TRANSGENIC MICE; THETA OSCILLATIONS; ENTORHINAL CORTEX; HORSERADISH-PEROXIDASE; NEURONAL OSCILLATIONS; GAMMA OSCILLATIONS;
D O I
10.1016/j.neurobiolaging.2016.04.016
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Alzheimer's disease is associated with cognitive decline and seizures. Growing evidence indicates that seizures contribute to cognitive deficits early in disease, but how they develop and impact cognition are unclear. To investigate potential mechanisms, we studied a mouse model that overexpresses mutant human amyloid precursor protein with high levels of amyloid beta (Ab). These mice develop generalized epileptiform activity, including nonconvulsive seizures, consistent with alterations in corticothalamic network activity. Amyloid precursor protein mice exhibited reduced activity marker expression in the reticular thalamic nucleus, a key inhibitory regulatory nucleus, and increased activity marker expression in downstream thalamic relay targets that project to cortex and limbic structures. Slice recordings revealed impaired cortical inputs to the reticular thalamic nucleus that may contribute to corticothalamic dysfunction. These results are consistent with our findings of impaired sleep maintenance in amyloid precursor protein mice. Finally, the severity of sleep impairments predicted the severity of deficits in Morris water maze, suggesting corticothalamic dysfunction may relate to hippocampal dysfunction, and may be a pathophysiological mechanism underlying multiple behavioral and cognitive alterations in Alzheimer's disease. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:96 / 107
页数:12
相关论文
共 50 条
  • [41] Erratum to: Dihydromyricetin Ameliorates Behavioral Deficits and Reverses Neuropathology of Transgenic Mouse Models of Alzheimer’s Disease
    Jing Liang
    Héctor E. López-Valdés
    Hilda Martínez-Coria
    A. Kerstin Lindemeyer
    Yi Shen
    Xuesi M. Shao
    Richard W. Olsen
    [J]. Neurochemical Research, 2014, 39 : 1403 - 1403
  • [42] Oleocanthal Ameliorates Metabolic and Behavioral Phenotypes in a Mouse Model of Alzheimer's Disease
    Yang, Euitaek
    Wang, Junwei
    Woodie, Lauren N.
    Greene, Michael W.
    Kaddoumi, Amal
    [J]. MOLECULES, 2023, 28 (14):
  • [43] Oral administration of methysticin improves cognitive deficits in a mouse model of Alzheimer's disease
    Fragoulis, Athanassios
    Siegl, Stephanie
    Fendt, Markus
    Jansen, Sandra
    Soppa, Ulf
    Brandenburg, Lars-Ove
    Pufe, Thomas
    Weis, Joachim
    Wruck, Christoph Jan
    [J]. REDOX BIOLOGY, 2017, 12 : 843 - 853
  • [44] Gastrodin alleviates memory deficits and reduces neuropathology in a mouse model of Alzheimer's disease
    Hu, Yikui
    Li, Chengyan
    Shen, Wei
    [J]. NEUROPATHOLOGY, 2014, 34 (04) : 370 - 377
  • [45] Behavioral and Neurochemical Alterations Induced by vanillin in a Mouse Model of Alzheimer's disease
    Abuhamdah, Sawsan
    Thalji, Duaa
    Abuirmeileh, Naji
    Bahnassi, Anas
    Salahat, Izzedin
    Abuirmeileh, Amjad
    [J]. INTERNATIONAL JOURNAL OF PHARMACOLOGY, 2017, 13 (06) : 573 - 582
  • [46] Targeting neurogenesis modifies behavioral symptoms in mouse model of Alzheimer's disease
    Offen, D.
    Shruster, A.
    [J]. JOURNAL OF MOLECULAR NEUROSCIENCE, 2014, 53 : S95 - S95
  • [47] Behavioral therapy reverses circadian deficits in a transgenic mouse model of Huntington's disease
    Cuesta, Marc
    Aungier, Juliet
    Morton, A. Jennifer
    [J]. NEUROBIOLOGY OF DISEASE, 2014, 63 : 85 - 91
  • [48] Early network dysfunction in Alzheimer's disease
    Selkoe, Dennis J.
    [J]. SCIENCE, 2019, 365 (6453) : 540 - +
  • [49] Neuromuscular Dysfunction Precedes Cognitive Impairment in a Mouse Model of Alzheimer's Disease
    Brisendine, Matthew H.
    Nichenko, Anna S.
    Bandara, Aloka B.
    Willoughby, Orion S.
    Amiri, Niloufar
    Weingrad, Zach
    Specht, Kalyn S.
    Bond, Jacob M.
    Addington, Adele
    Jones III, Ronald G.
    Murach, Kevin A.
    Poelzing, Steven
    Craige, Siobhan M.
    Grange, Robert W.
    Drake, Joshua C.
    [J]. FUNCTION, 2023, 5 (01):
  • [50] CXCR3 promotes plaque formation and behavioral deficits in an Alzheimer's disease model
    Krauthausen, Marius
    Kummer, Markus P.
    Zimmermann, Julian
    Reyes-Irisarri, Elisabet
    Terwel, Dick
    Bulic, Bruno
    Heneka, Michael T.
    Mueller, Marcus
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2015, 125 (01): : 365 - 378